tradingkey.logo
tradingkey.logo
Search

Vir Biotechnology Inc

VIR
Add to Watchlist
8.660USD
-0.240-2.70%
Close 07-31 16:00ETQuotes delayed by 15 min
1.46BMarket Cap
LossP/E TTM

VIR Financials

See Vir Biotechnology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Vir Biotechnology Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/0.33
Revenue / Forecast
--/216.46M
Period
FY2025 Earnings
Revenue(YoY)
68.56M
-7.61%
EPS(YoY)
-3.16
17.47%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
3.06%-0.85
59.67%-0.31
24.92%-1.17
21.10%-0.80
-82.36%-0.88
11.26%-0.76
-28.52%-1.56
30.09%-1.02
54.26%-0.48
-12.91%-0.86
---1.22
---1.45
---1.06
---0.76
--4.66
----
----
----
----
----
Revenue
-100.96%-29.00K
417.78%64.07M
-89.92%240.00K
-60.52%1.21M
-94.62%3.03M
-26.29%12.37M
-9.81%2.38M
-19.02%3.08M
-10.45%56.38M
-66.03%16.79M
-99.30%2.64M
109.35%3.80M
-94.89%62.96M
-93.92%49.41M
261.49%374.56M
-122.95%-40.63M
62271.41%1.23B
46771.22%812.75M
5274.27%103.62M
164.33%177.07M
Net Profit
-3.91%-125.69M
58.96%-42.92M
23.66%-163.14M
19.82%-110.96M
-85.31%-120.97M
9.82%-104.59M
-30.78%-213.72M
28.95%-138.38M
53.67%-65.28M
-14.14%-115.97M
-193.21%-163.41M
-154.63%-194.78M
-127.17%-140.90M
-119.34%-101.60M
58.76%175.31M
-223.75%-76.49M
407.04%518.62M
597.17%525.25M
230.52%110.43M
298.33%61.81M
Net Margin
----
92.07%-66.99%
-656.99%-67975.42%
-103.10%-9139.87%
-3345.65%-3989.61%
-22.35%-845.23%
-45.02%-8979.71%
12.27%-4500.10%
48.28%-115.79%
-235.96%-690.85%
---6192.23%
---5129.71%
---223.89%
---205.63%
--39.42%
----
----
----
----
----
Gross Margin
----
5.81%99.96%
6.83%104.58%
0.80%99.09%
0.10%100.00%
-0.81%94.47%
-0.67%97.90%
-1.12%98.31%
3.02%99.90%
8.40%95.25%
--98.56%
--99.42%
--96.97%
--87.86%
--91.04%
----
----
----
----
----
Debt to assets ratio
----
--0.00%
----
----
----
--0.00%
--0.00%
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Revenue
-100.96%-29.00K
417.78%64.07M
-89.92%240.00K
-60.52%1.21M
-94.62%3.03M
-26.29%12.37M
-9.81%2.38M
-19.02%3.08M
-10.45%56.38M
-66.03%16.79M
-99.30%2.64M
109.35%3.80M
-94.89%62.96M
-93.92%49.41M
261.49%374.56M
-122.95%-40.63M
62271.41%1.23B
46771.22%812.75M
5274.27%103.62M
164.33%177.07M
Operating profit
5.21%-132.29M
60.43%-47.92M
20.65%-173.44M
10.40%-118.59M
-74.17%-139.56M
12.89%-121.09M
-17.06%-218.59M
38.49%-132.35M
44.11%-80.13M
7.63%-139.02M
-195.78%-186.73M
4.46%-215.19M
-114.14%-143.37M
-126.32%-150.50M
465.20%194.96M
-469.11%-225.22M
739.10%1.01B
627.43%571.75M
39.07%-53.38M
310.03%61.02M
Net Profit
-3.91%-125.69M
58.96%-42.92M
23.66%-163.14M
19.82%-110.96M
-85.31%-120.97M
9.82%-104.59M
-30.78%-213.72M
28.95%-138.38M
53.67%-65.28M
-14.14%-115.97M
-193.21%-163.41M
-154.63%-194.78M
-127.17%-140.90M
-119.34%-101.60M
58.76%175.31M
-223.75%-76.49M
407.04%518.62M
597.17%525.25M
230.52%110.43M
298.33%61.81M
Current assets
-43.90%522.99M
-50.69%514.08M
-47.89%545.68M
-38.98%735.71M
-23.15%932.21M
-34.36%1.04B
-40.81%1.05B
-38.05%1.21B
-48.57%1.21B
-36.95%1.59B
-26.70%1.77B
-14.94%1.95B
-8.14%2.36B
61.19%2.52B
126.35%2.41B
165.37%2.29B
158.54%2.57B
102.34%1.56B
25.51%1.07B
48.99%862.29M
Total current liabilities
-46.42%73.56M
-22.44%92.81M
-35.80%75.22M
8.91%105.00M
45.94%137.29M
-31.78%119.66M
-29.01%117.16M
-57.27%96.41M
-80.62%94.07M
-65.68%175.41M
-46.45%165.05M
-52.79%225.62M
-30.91%485.29M
49.76%511.03M
31.87%308.20M
227.25%477.87M
94.51%702.36M
244.47%341.24M
203.55%233.72M
165.79%146.02M
Total assets
-21.57%1.03B
-28.31%1.00B
-31.96%1.02B
-28.57%1.19B
-27.10%1.31B
-27.11%1.40B
-26.73%1.50B
-25.59%1.67B
-32.71%1.79B
-31.51%1.92B
-24.15%2.04B
-14.32%2.24B
-7.66%2.67B
43.38%2.80B
122.77%2.70B
147.64%2.62B
154.24%2.89B
112.71%1.95B
28.30%1.21B
57.32%1.06B
Total liabilities
-19.36%212.82M
-4.38%237.55M
-13.30%223.35M
3.89%245.06M
7.01%263.91M
-24.45%248.43M
-30.33%257.63M
-45.61%235.88M
-64.52%246.61M
-54.59%328.82M
-32.28%369.81M
-34.98%433.67M
-21.55%695.13M
38.61%724.13M
63.54%546.12M
108.27%666.98M
82.84%886.12M
158.74%522.42M
155.10%333.94M
195.28%320.26M
Total equity
-22.14%812.76M
-33.48%765.28M
-35.84%796.10M
-33.91%947.47M
-32.54%1.04B
-27.66%1.15B
-25.93%1.24B
-20.80%1.43B
-21.49%1.55B
-23.47%1.59B
-22.08%1.68B
-7.26%1.81B
-1.51%1.97B
45.12%2.08B
145.34%2.15B
164.74%1.95B
207.40%2.00B
99.74%1.43B
7.87%876.27M
30.78%737.33M
Net operating income
-69.47%-132.39M
70.47%-25.88M
2.28%-167.57M
-54.43%-120.22M
28.59%-78.12M
18.80%-87.64M
-10.04%-171.48M
80.00%-77.85M
13.03%-109.39M
-407.26%-107.93M
-232.17%-155.83M
-140.54%-389.25M
-122.87%-125.78M
356.48%35.13M
211.42%117.90M
585.53%960.14M
714.43%550.09M
109.38%7.70M
-112.30%-105.81M
1416.46%140.06M
Net investment
-90.67%11.84M
-38.43%86.65M
-65.90%40.45M
-73.32%56.46M
346.23%126.82M
234.28%140.74M
301.18%118.60M
-8.12%211.61M
-71.02%28.42M
31.56%-104.81M
91.10%-58.95M
184.57%230.31M
193.06%98.08M
59.44%-153.13M
-997.12%-662.61M
-461.30%-272.33M
-220.40%-105.39M
-721.91%-377.58M
139.84%73.86M
612.09%75.38M
Net financing
27077.76%162.52M
-17.74%1.04M
229.03%102.00K
-30.46%2.05M
293.42%598.00K
-24.82%1.26M
-88.81%31.00K
-7.46%2.94M
-93.52%152.00K
-16.46%1.68M
-86.05%277.00K
3.21%3.18M
-91.53%2.34M
-64.53%2.01M
-45.30%1.98M
-12.72%3.08M
-68.36%27.68M
2289.19%5.67M
-98.88%3.63M
-98.28%3.53M

FAQs

What is the total revenue of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its total revenue reached 68.56M, with a year-on-year change of 74.20M.

What are the current assets of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its current assets were 514.08M, with a year-on-year change of -50.69.

What are the total assets of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its total assets of Vir Biotechnology Inc were 1.00B, with a year-on-year change of -28.31.

What are the total liabilities of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its total liabilities of Vir Biotechnology Inc were 237.55M, with a year-on-year change of -4.38.

What is the total equity of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its total equity of Vir Biotechnology Inc was 765.28M, with a year-on-year change of -33.48.

What is the net operating income of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its net operating income of Vir Biotechnology Inc was -479.51M, with a year-on-year change of 13.16.

What is the net investment of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its net investment of Vir Biotechnology Inc was 310.37M, with a year-on-year change of -37.85.

What is the net financing of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its net financing of Vir Biotechnology Inc was 3.79M, with a year-on-year change of -13.74.

What is the Earnings Per Share (EPS) of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.16, with a year-on-year change of 17.47.

What is the net income of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its net income was -437.99M, with a year-on-year change of 16.09.

What is the net margin of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its net profit margin was -638.87, with a year-on-year change of 9.17.

What is the gross margin of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its gross margin was 99.96, with a year-on-year change of 1.11.

What is the Return on Equity (ROE) of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its Return on Equity (ROE) was -45.73, with a year-on-year change of -20.05.

What is the Return on Assets (ROA) of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its Return on Assets (ROA) was -36.47, with a year-on-year change of -15.92.

What is the operating profit of Vir Biotechnology Inc?

According to Vir Biotechnology Inc's FY2025 earnings report, its operating profit was -479.51M, with a year-on-year change of 13.16.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.